Surgery pp 1413-1428 | Cite as

Arterial Disease of the Lower Extremity

  • Michael A. Golden


The overwhelming majority of vascular disease of the lower extremities is secondary to atherosclerosis. Depending on the severity of the vascular lesions and the existing collateral circulation, symptoms generally follow a continuum ranging from claudication to rest pain to frank gangrene with tissue loss. A primary goal of the vascular surgeon is the preservation of limb function by risk factor management and appropriate timing of vascular reconstruction.


Limb Salvage Popliteal Artery Superficial Femoral Artery Intermittent Claudication Deep Femoral Artery 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982;211:249–256.PubMedGoogle Scholar
  2. 2.
    Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986;293:1137–1140.CrossRefGoogle Scholar
  3. 3.
    Imparato AM, Kim GE, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery (St. Louis) 1975;78:795–799.PubMedGoogle Scholar
  4. 4.
    Cronenwett JL, Warner KG, Zelenock GB, et al. Intermittent claudication. Current results of nonoperative management. Arch Surg 1984;119:430–436.PubMedGoogle Scholar
  5. 5.
    McCann RL. Peripheral artery aneurysms. In: Porter JM, Taylor LM Jr, eds. Basic Data Underlying Clinical Decision Making in Vascular Surgery. St. Louis: Quality Medical, 1994:137–140.Google Scholar
  6. 6.
    Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384–392.PubMedCrossRefGoogle Scholar
  7. 7.
    Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985;33:13–18.PubMedGoogle Scholar
  8. 8.
    Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981;34:261–269.PubMedCrossRefGoogle Scholar
  9. 9.
    Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg 1989;30:50–57.Google Scholar
  10. 10.
    Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992;45:529–542.PubMedCrossRefGoogle Scholar
  11. 11.
    Farkouh ME, Rihal CS, Gersh BJ, et al. Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: a population-based study in Olmsted County, Minnesota (1970–1987). J Am Coll Cardiol 1994;24:1290–1296.PubMedCrossRefGoogle Scholar
  12. 12.
    Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985;218:27–33.PubMedGoogle Scholar
  13. 13.
    Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA 1972;221:661–666.PubMedCrossRefGoogle Scholar
  14. 14.
    Kannel WB, Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics 1973;28:61–68.PubMedGoogle Scholar
  15. 15.
    Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978;1:1379–1381.PubMedCrossRefGoogle Scholar
  16. 16.
    Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970;41:875–883.PubMedGoogle Scholar
  17. 17.
    Goodreau JJ, Creasy JK, Flanigan P, et al. Rational approach to the differentiation of vascular and neurogenic claudication. Surgery (St. Louis) 1978;84:749–757.PubMedGoogle Scholar
  18. 18.
    Barnes RW. Noninvasive diagnostic assessment of peripheral vascular disease. Circulation 1991;83(suppl):I20–I27.PubMedGoogle Scholar
  19. 19.
    Anonymous. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery [published erratum appears in J Vasc Surg 1986;4(4):350]. J Vasc Surg 1986;4:80–94.Google Scholar
  20. 20.
    Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy. Arteriosclerosis 1982;2:275–280.PubMedGoogle Scholar
  21. 21.
    Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18–20, 1992, New Orleans, Louisiana [see comments]. Circulation 1993;88:819–828.PubMedGoogle Scholar
  22. 22.
    Strandness DE Jr. Peripheral arterial system. In: Duplex Scanning in Vascular Disorders. New York: Raven Press, 1993:159–195.Google Scholar
  23. 23.
    Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness DE Jr. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study. Circulation 1987;76:1074–1080.PubMedGoogle Scholar
  24. 24.
    Auerbach EG, Martin ET. Magnetic resonance imaging of the peripheral vasculature. Am Heart J 2004;148(5):755–763.PubMedCrossRefGoogle Scholar
  25. 25.
    Romano M, Mainenti PP, Imbriaco M, et al. Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease. Diagnostic accuracy and interobserver agreement. Eur J Radiol 2004;50:303–308.PubMedCrossRefGoogle Scholar
  26. 26.
    Boyd AM. The natural course of arteriosclerosis of the lower extremities. Proc R Soc Med 1962;55:591–593.PubMedGoogle Scholar
  27. 27.
    Bowers BL, Valentine RJ, Myers SI, Chervu A, Clagett GP. The natural history of patients with claudication with toe pressures of 40mmHg or less. J Vasc Surg 1993;18:506–511.PubMedCrossRefGoogle Scholar
  28. 28.
    Zannetti S, L’Italien GJ, Cambria RP. Functional outcome after surgical treatment for intermittent claudication. J Vasc Surg 1996;24:65–73.PubMedCrossRefGoogle Scholar
  29. 29.
    Abbott WM, Kwolek CJ. Aortofemoral bypass for atherosclerotic aortoiliac occlusive disease. In: Ernst CB, Stanley JC, eds. Current Therapy in Vascular Surgery. St. Louis: Mosby-Year Book, 1995:355–359.Google Scholar
  30. 30.
    Poulias GE, Doundoulakis N, Prombonas E, et al. Aorto-femoral bypass and determinants of early success and late favourable outcome. Experience with 1000 consecutive cases. J Cardiovasc Surg 1992;33:664–678.Google Scholar
  31. 31.
    Prendiville EJ, Burke PE, Colgan MP, Wee BL, Moore DJ, Shanik DG. The profunda femoris: a durable outflow vessel in aortofemoral surgery. J Vasc Surg 1992;16:23–29.PubMedCrossRefGoogle Scholar
  32. 32.
    Brewster DC, Darling RC. Optimal methods of aortoiliac reconstruction. Surgery (St. Louis) 1978;84:739–748.PubMedGoogle Scholar
  33. 33.
    Piotrowski JJ, Pearce WH, Jones DN, et al. Aortobifemoral bypass: the operation of choice for unilateral iliac occlusion? [see comments]. J Vasc Surg 1988;8:211–218.PubMedCrossRefGoogle Scholar
  34. 34.
    van der Vliet JA, Scharn DM, de Waard JW, Roumen RM, van Roye SF, Buskens FG. Unilateral vascular reconstruction for iliac obstructive disease. J Vasc Surg 1994;19:610–614.PubMedGoogle Scholar
  35. 35.
    Mannick JA, Whittemore AD. Aortoiliac occlusive disease. In: Moore WS, ed. Vascular Surgery: A Comprehensive Review. Philadelphia: Saunders, 1991:350–363.Google Scholar
  36. 36.
    Taylor LM Jr, Moneta GL, McConnell D, Yeager RA, Edwards JM, Porter JM. Axillofemoral grafting with externally supported polytetrafluoroethylene. Arch Surg 1994;129:588–594; discussion 594–595.PubMedGoogle Scholar
  37. 37.
    Criado E, Johnson G Jr, Burnham SJ, Buehrer J, Keagy BA. Descending thoracic aorta-to-iliofemoral artery bypass as an alternative to aortoiliac reconstruction. J Vasc Surg 1992;15:550–557.PubMedCrossRefGoogle Scholar
  38. 38.
    Sanchez LA, Wain RA, Veith FJ, Cynamon J, Lyon RT, Ohki T. Endovascular grafting for aortoiliac occlusive disease. Semin Vasc Surg 1997;10:297–309.PubMedGoogle Scholar
  39. 39.
    Donaldson MC, Mannick JA. Femoropopliteal bypass grafting for intermittent claudication: is pessimism warranted? Arch Surg 1980;115:724–727.PubMedGoogle Scholar
  40. 40.
    Dalman RL, Taylor LM Jr. Infrainguinal revascularization procedures. In: Porter JM, Taylor LM Jr, eds. Basic Data Underlying Clinical Decision Making in Vascular Surgery. St. Louis: Quality Medical, 1994:141–143.Google Scholar
  41. 41.
    Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA, Whittemore AD. Femorotibial bypass for claudication: do results justify an aggressive approach? J Vasc Surg 1995;21:873–880.PubMedCrossRefGoogle Scholar
  42. 42.
    Veith FJ, Gupta SK, Wengerter KR, Rivers SP. Femoralpopliteal-tibial occlusive disease. In: Moore WS, ed. Vascular Surgery: A Comprehensive Review. Philadelphia: Saunders, 1991:364–389.Google Scholar
  43. 43.
    Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multi-center randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104–114.PubMedCrossRefGoogle Scholar
  44. 44.
    Berlakovich GA, Herbst F, Mittlbock M, Kretschmer G. The choice of material for above-knee femoropopliteal bypass. A 20-year experience. Arch Surg 1994;129:297–302.PubMedGoogle Scholar
  45. 45.
    Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995;10:356–361.PubMedCrossRefGoogle Scholar
  46. 46.
    Raftery KB, Belkin M, Mackey WC, O’Donnell TF. Are peroneal artery bypass grafts hemodynamically inferior to other tibial artery bypass grafts? J Vasc Surg 1994;19:964–968; discussion 968–969.PubMedGoogle Scholar
  47. 47.
    Harris PL, Veith FJ, Shanik GD, Nott D, Wengerter KR, Moore DJ. Prospective randomized comparison of in situ and reversed infrapopliteal vein grafts [see comments]. Br J Surg 1993;80:173–176.PubMedCrossRefGoogle Scholar
  48. 48.
    Shah DM, Darling RC III, Chang BB, Kalufman JL, Fitzgerald KM, Leather RP. Is long vein bypass from groin to ankle a durable procedure? An analysis of a ten-year experience. J Vasc Surg 1992;15:402–407; discussion 407–408.PubMedCrossRefGoogle Scholar
  49. 49.
    Wengerter KR, Yang PM, Veith FJ, Gupta SK, Panetta TF. A twelve-year experience with the popliteal-to-distal artery bypass: the significance and management of proximal disease. J Vasc Surg 1992;15:143–149; discussion 150–151.PubMedCrossRefGoogle Scholar
  50. 50.
    Ballard JL, Killeen JD, Smith LL. Popliteal-tibial bypass grafts in the management of limb-threatening ischemia. Arch Surg 1993;128:976–980; discussion 980–981.PubMedGoogle Scholar
  51. 51.
    Darling RC III, Chang BB, Shah DM, Leather RP. Choice of peroneal or dorsalis pedis artery bypass for limb salvage. Semin Vasc Surg 1997;10:17–22.PubMedGoogle Scholar
  52. 52.
    LoGerfo FW, Gibbons GW, Pomposelli FB Jr, et al. Trends in the care of the diabetic foot. Expanded role of arterial reconstruction. Arch Surg 1992;127:617–620; discussion 620–621.PubMedGoogle Scholar
  53. 53.
    Mills JL, Taylor SM, Fujitani RM. The role of the deep femoral artery as an inflow site for infrainguinal revascularization. J Vasc Surg 1993;18:416–423.PubMedCrossRefGoogle Scholar
  54. 54.
    Bandyk DF. Surveillance of lower extremity bypass grafts. In: Ernst CB, Stanley JC, eds. Current Therapy in Vascular Surgery. St. Louis: Mosby-Year Book, 1995:492–499.Google Scholar
  55. 55.
    Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a technique and a preliminary report of its application. Circulation 1964;30:654–670.PubMedGoogle Scholar
  56. 56.
    Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease [published erratum appears in Radiology 1997;205(2):584]. Radiology 1997;204:87–96.PubMedGoogle Scholar
  57. 57.
    Wilson SE, Sheppard B. Results of percutaneous transluminal angioplasty for peripheral vascular occlusive disease. In: Porter JM, Taylor LM Jr, eds. Basic Data Underlying Clinical Decision Making in Vascular Surgery. St. Louis: Quality Medical, 1994:144–148.Google Scholar
  58. 58.
    Johnston KW, Rae M, Hogg-Johnston SA, et al. 5-Year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206:403–413.PubMedCrossRefGoogle Scholar
  59. 59.
    Ruef J, Hofmann M, Haase J. Endovascular interventions in iliac and infrainguinal occlusive artery disease. J Intervent Cardiol 2004;17(6):427–435.PubMedCrossRefGoogle Scholar
  60. 60.
    Johnson WC, Watkins MT, Baldwin D, Hamilton J. Foot TcPO2 response to lumbar sympathectomy in patients with focal ischemic necrosis. Ann Vasc Surg 1998;12:70–74.PubMedCrossRefGoogle Scholar
  61. 61.
    Van Driel OJR, van Bockel JH, Schilfgaarde R. Lumbar sympathectomy for severe lower limb ischemia: results and analysis. J Cardiovasc Surg 1988;29:310–314.Google Scholar
  62. 62.
    Hourlay P, Vangertruyden G, Verduyckt F, Trimpeneers F, Hendrickx J. Endoscopic extraperitoneal lumbar sympathectomy. Surg Endosc 1995;9:530–533.PubMedCrossRefGoogle Scholar
  63. 63.
    Robbs JV, Ray R. Clinical predictors of below-knee stump healing following amputation for ischaemia. South Air J Surgery 1982;20:305–310.Google Scholar
  64. 64.
    Dwars BJ, van den Broek TA, Rauwerda JA, Bakker FC. Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease. J Vasc Surg 1992;15:536–542.PubMedCrossRefGoogle Scholar
  65. 65.
    Little JM, Stephen MS, Zylstra PL. Amputation of the toes for vascular disease: fate of the affected leg. Lancet 1976;2:1318–1319.PubMedCrossRefGoogle Scholar
  66. 66.
    Yeager RA, Moneta GL, Taylor LM Jr, Hamre DW, McConnell DB, Porter JM. Surgical management of severe acute lower extremity ischemia. J Vasc Surg 1992;15:385–391; discussion 392–393.PubMedCrossRefGoogle Scholar
  67. 67.
    Mills JL, Porter JM. Acute limb ischemia. In: Porter JM, Taylor LM Jr, eds. Basic Data Underlying Clinical Decision Making in Vascular Surgery. St. Louis: Quality Medical, 1994:134–136.Google Scholar
  68. 68.
    Anonymous. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994;220:251–266; discussion 266–268.Google Scholar
  69. 69.
    Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators [see comments]. J Vasc Surg 1996;23:64–73; discussion 74–75.PubMedCrossRefGoogle Scholar
  70. 70.
    Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators [see comments]. N Engl J Med 1998;338:1105–1111.PubMedCrossRefGoogle Scholar
  71. 71.
    Karmody AM, Powers SR, Monaco VJ, Leather RP. “Blue toe” syndrome. An indication for limb salvage surgery. Arch Surg 1976;111:1263–1268.PubMedGoogle Scholar
  72. 72.
    Blackshear JL, Zabalgoitia M, Pennock G, et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators: Stroke Prevention and Atrial Fibrillation; Transesophageal Echocardiography. Am J Cardiol 1999;83:453–455; A9.PubMedCrossRefGoogle Scholar
  73. 73.
    Graham LM, Zelenock GB, Whitehouse WM Jr, et al. Clinical significance of arteriosclerotic femoral artery aneurysms. Arch Surg 1980;115:502–507.PubMedGoogle Scholar
  74. 74.
    Cutler BS. Arteriosclerotic femoral artery aneurysm. In: Ernst CB, Stanley JC, eds. Current Therapy in Vascular Surgery. St. Louis: Mosby, 1995:315–318.Google Scholar
  75. 75.
    Cutler BS, Darling RC. Surgical management of arteriosclerotic femoral aneurysms. Surgery (St. Louis) 1973;74:764–773.PubMedGoogle Scholar
  76. 76.
    Michel C, Laffy PY, Leblanc G, et al. Percutaneous treatment of a superficial femoral artery aneurysm using an intravascular stent-prosthesis (in French). J Radiol 1999;80:473–476.PubMedGoogle Scholar
  77. 77.
    Schneider PA. Abcarian PW, Leduc JR, Ogawa DY. Stent-graft repair of mycotic superficial femoral artery aneurysm using a Palmaz stent and autologous saphenous vein. Ann Vasc Surg 1998;12:282–285.PubMedCrossRefGoogle Scholar
  78. 78.
    Szilagyi DE, Schwartz RL, Reddy DJ. Popliteal arterial aneurysms. Their natural history and management. Arch Surg 1981;116:724–728.PubMedGoogle Scholar
  79. 79.
    Reilly MK, Abbott WM, Darling RC. Aggressive surgical management of popliteal artery aneurysms. Am J Surg 1983;145:498–502.PubMedCrossRefGoogle Scholar
  80. 80.
    Evans WE, Vermilion BD. Popliteal aneurysms. In: Bergan JJ, Yao JST, eds. Aneurysms: Diagnosis and Treatment. New York: Grune & Stratton, 1982:487.Google Scholar
  81. 81.
    Shortell C, DeWeese JA, Ouriel K, Green RM. Popliteal artery aneurysms: a 25-year surgical experience. J Vasc Surg 1991;14:771–776; discussion 776–779.PubMedCrossRefGoogle Scholar
  82. 82.
    Carpenter JP, Barker CF, Roberts B, Berkowitz HD, Lusk EJ, Perloff LJ. Popliteal artery aneurysms: current management and outcome [see comments]. J Vasc Surg 1994;19:65–72; discussion 72–73.PubMedGoogle Scholar
  83. 83.
    Kudelko PE Jr, Alfaro-Franco C, Diethrich EB, Krajcer Z. Successful endoluminal repair of a popliteal artery aneurysm using the Wallgraft endoprosthesis. J Endovasc Surg 1998;5:373–377.PubMedCrossRefGoogle Scholar
  84. 84.
    McCann RL, Schwartz LB, Pieper KS. Vascular complications of cardiac catheterization. J Vasc Surg 1991;14:375–381.PubMedCrossRefGoogle Scholar
  85. 85.
    Weatherford DA, Taylor SM, Langan EM, Coffey CB, Alfieri MA. Ultrasound-guided compression for the treatment of iatrogenic femoral pseudoaneurysms. South Med J 1997;90:223–226.PubMedGoogle Scholar
  86. 86.
    Liau CS, Ho FM, Chen MF, Lee YT. Treatment of iatrogenic femoral artery pseudoaneurysm with percutaneous thrombin injection. J Vasc Surg 1997;26:18–23.PubMedCrossRefGoogle Scholar
  87. 87.
    Rich NM, Collins GJ Jr, McDonald PT, Kozloff L, Clagett GP, Collins JT. Popliteal vascular entrapment. Its increasing interest. Arch Surg 1979;114:1377–1384.PubMedGoogle Scholar
  88. 88.
    Turnipseed WD. Popliteal vascular entrapment syndrome. In: Ernst CB, Stanley JC, eds. Current Therapy in Vascular Surgery. St. Louis: Mosby, 1995:504–508.Google Scholar
  89. 89.
    Jay GD, Ross FL, Mason RA, Giron F. Clinical and chemical characterization of an adventitial popliteal cyst. J Vasc Surg 1989;9:448–451.PubMedCrossRefGoogle Scholar
  90. 90.
    Melliere D, Ecollan P, Kassab M, Becqemin JP. Adventitial cystic disease of the popliteal artery: treatment by cyst removal. J Vasc Surg 1988;8:638–642.PubMedCrossRefGoogle Scholar
  91. 91.
    Samson RH, Willis PD. Popliteal artery occlusion caused by cystic adventitial disease: successful treatment by urokinase followed by nonresectional cystotomy. J Vasc Surg 1990;12:591–593.PubMedCrossRefGoogle Scholar
  92. 92.
    McKusick VA. Buerger’s disease: a distinct clinical and pathological entity. JAMA 1962;181:5–12.Google Scholar
  93. 93.
    Rivera R. Roentgenographs diagnosis of Buerger’s disease. J Cardiovasc Surg 1973;14:40–46.Google Scholar
  94. 94.
    Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193–205.PubMedCrossRefGoogle Scholar
  95. 95.
    Bergan JJ, Veith FJ, Bernhard VM, et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery (St. Louis) 1982;92:921–930.PubMedGoogle Scholar
  96. 96.
    Rutherford RB, Jones DN, Bergentz SE, et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988;8:236–246.PubMedCrossRefGoogle Scholar
  97. 97.
    Kent KC, Whittemore AD, Mannick JA. Short-term and midterm results of an all-autogenous tissue policy for infrainguinal reconstruction. J Vasc Surg 1989;9:107–114.PubMedCrossRefGoogle Scholar
  98. 98.
    Brewster DC, LaSalle AJ, Darling RC. Comparison of above-knee and below-knee anastomosis in femoropopliteal bypass grafts. Arch Surg 1981;116:1013–1018.PubMedGoogle Scholar
  99. 99.
    Hall RG, Coupland GA, Lane R, Delbridge L, Appleberg M. Vein, Gore-Tex or a composite graft for femoropopliteal bypass. Surg Gynecol Obstet 1985;161:308–312.PubMedGoogle Scholar
  100. 100.
    Davies MG, Dalen H, Svendsen E, Hagen PO. The functional and morphological consequences of balloon catheter injury in veins. J Surg Res 1994;57:122–132.PubMedCrossRefGoogle Scholar
  101. 101.
    Quinones-Baldrich WJ, Busuttil RW, Baker JD, et al. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? [see comments]. J Vasc Surg 1988;8:219–228.PubMedCrossRefGoogle Scholar
  102. 102.
    Anonymous. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Veterans Administration Cooperative Study Group 141. Arch Surg 1988;123:434–438.Google Scholar
  103. 103.
    Hobson RW Jr, Lynch TG, Jamil Z, et al. Results of revascularization and amputation in severe lower extremity ischemia: a five-year clinical experience. J Vasc Surg 1985;2:174–185.PubMedCrossRefGoogle Scholar
  104. 104.
    Harris RW, Andros G, Dulawa LB, Oblath RW, Apyan R, Salles-Cunha S. The transition to “in situ” vein bypass grafts. Surg Gynecol Obstet 1986;163:21–28.PubMedGoogle Scholar
  105. 105.
    Leather RP, Shah DM, Chang BB, Kaufman JL. Resurrection of the in situ saphenous vein bypass. 1000 cases later [see comments]. Ann Surg 1988;208:435–442.PubMedCrossRefGoogle Scholar
  106. 106.
    Bandyk DF, Kaebnick HW, Stewart GW, Towne JB. Durability of the in situ saphenous vein arterial bypass: a comparison of primary and secondary patency. J Vasc Surg 1987;5:256–268.PubMedCrossRefGoogle Scholar
  107. 107.
    Varty K, Allen KE, Jones L, Sayers RD, Bell PR, London NJ. Influence of Losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein. Br J Surg 1994;81:819–822.PubMedCrossRefGoogle Scholar
  108. 108.
    Barry R, Satiani B, Mohan B, Smead WL, Vaccaro PS. Prognostic indicators in femoropopliteal and distal bypass grafts. Surg Gynecol Obstet 1985;161:129–132.PubMedGoogle Scholar
  109. 109.
    Cantelmo NL, Snow JR, Menzoian JO, LoGerfo FW. Successful vein bypass in patients with an ischemic limb and a palpable popliteal pulse. Arch Surg 1986;121:217–220.PubMedGoogle Scholar
  110. 110.
    Schuler JJ, Flanigan DP, Williams LR, Ryan TJ, Castronuovo JJ. Early experience with popliteal to infrapopliteal bypass for limb salvage. Arch Surg 1983;118:472–476.PubMedGoogle Scholar
  111. 111.
    Berkowitz HD, Greenstein SM. Improved patency in reversed femoral-infrapopliteal autogenous vein grafts by early detection and treatment of the failing graft. J Vasc Surg 1987;5:755–761.PubMedCrossRefGoogle Scholar
  112. 112.
    Dalsing MC, White JV, Yao JS, Podrazik R, Flinn WR, Bergan JJ. Infrapopliteal bypass for established gangrene of the forefoot or toes. J Vasc Surg 1985;2:669–677.PubMedCrossRefGoogle Scholar
  113. 113.
    Rosenbloom MS, Walsh JJ, Schuler JJ, et al. Long-term results of infragenicular bypasses with autogenous vein originating from the distal superficial femoral and popliteal arteries. J Vasc Surg 1988;7:691–696.PubMedCrossRefGoogle Scholar
  114. 114.
    Flinn WR, Rohrer MJ, Yao JS, McCarthy WJ III, Fahey VA, Bergan JJ. Improved long-term patency of infragenicular polytetrafluoroethylene grafts. J Vasc Surg 1988;7:685–690.PubMedCrossRefGoogle Scholar
  115. 115.
    Taylor LM Jr, Edwards JM, Brant B, Phinney ES, Porter JM. Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein. Am J Surg 1987;153:505–510.PubMedCrossRefGoogle Scholar
  116. 116.
    Leather RP, Shan DM, Karmody AM. Infrapopliteal arterial bypass for limb salvage: increased patency and utilization of the saphenous vein used “in situ.” Surgery (St. Louis) 1981;90:1000–1008.PubMedGoogle Scholar
  117. 117.
    Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70:619–623.PubMedGoogle Scholar
  118. 118.
    Hewes RC, White RI Jr, Murray RR, et al. Long-term results of superficial femoral artery angioplasty. AJR Am J Roentgenol 1986;146:1025–1029.PubMedGoogle Scholar
  119. 119.
    Spence RK, Freiman DB, Gatenby R, et al. Long-term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg 1981;116:1377–1386.PubMedGoogle Scholar
  120. 120.
    Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985;156:325–328.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Michael A. Golden
    • 1
  1. 1.Division of Vascular Surgery and Endovascular Therapy, Department of SurgeryPenn Presbyterian Medical CenterPhiladelphiaUSA

Personalised recommendations